TY - JOUR
T1 - Summary of Japanese clinical practice guidelines for head and neck cancer - 2022 update edited by the Japan society for head and neck cancer
AU - Homma, Akihiro
AU - Ando, Mizuo
AU - Hanai, Nobuhiro
AU - Harada, Hiroyuki
AU - Honma, Yoshitaka
AU - Kanda, Tomonori
AU - Kano, Satoshi
AU - Kawakita, Daisuke
AU - Kiyota, Naomi
AU - Kizawa, Yoshiyuki
AU - Nakagawa, Masahiro
AU - Ogawa, Takenori
AU - Shinomiya, Hirotaka
AU - Shinozaki, Takeshi
AU - Suzuki, Motoyuki
AU - Tsuji, Tetsuya
AU - Yasuda, Koichi
AU - Zenda, Sadamoto
AU - Kodaira, Takeshi
AU - Kirita, Tadaaki
AU - Nibu, Ken ichi
N1 - Publisher Copyright:
© 2023
PY - 2024/2
Y1 - 2024/2
N2 - The aim of the “Japanese Clinical Practice Guidelines for Head and Neck Cancer - 2022 Update” is to review the latest evidence regarding head and neck cancer and to present the current standard approaches for diagnosis and treatment. These evidence-based recommendations were created with the consensus of the Guideline Committee, which is composed of otorhinolaryngologists and head and neck surgeons, together with radiologists, radiation oncologists, medical oncologists, plastic surgeons, dentists, palliative care physicians, and rehabilitation physicians. These guidelines were created by the Clinical Practice Guideline Committee of the Japan Society for Head and Neck Cancer based on the “Head and Neck Cancer Treatment Guidelines 2018 Edition,” and the revised draft was compiled after evaluation by the Assessment Committee and public comments. The ‘Clinical questions and recommendations’ section consists of 13 categories, and 59 clinical questions are described in total. Here we describe 6 clinical questions specific to other sets of guidelines with recommendations and comments.
AB - The aim of the “Japanese Clinical Practice Guidelines for Head and Neck Cancer - 2022 Update” is to review the latest evidence regarding head and neck cancer and to present the current standard approaches for diagnosis and treatment. These evidence-based recommendations were created with the consensus of the Guideline Committee, which is composed of otorhinolaryngologists and head and neck surgeons, together with radiologists, radiation oncologists, medical oncologists, plastic surgeons, dentists, palliative care physicians, and rehabilitation physicians. These guidelines were created by the Clinical Practice Guideline Committee of the Japan Society for Head and Neck Cancer based on the “Head and Neck Cancer Treatment Guidelines 2018 Edition,” and the revised draft was compiled after evaluation by the Assessment Committee and public comments. The ‘Clinical questions and recommendations’ section consists of 13 categories, and 59 clinical questions are described in total. Here we describe 6 clinical questions specific to other sets of guidelines with recommendations and comments.
KW - Clinical practice guideline
KW - Clinical question
KW - Head and neck cancer
UR - http://www.scopus.com/inward/record.url?scp=85165706403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165706403&partnerID=8YFLogxK
U2 - 10.1016/j.anl.2023.07.003
DO - 10.1016/j.anl.2023.07.003
M3 - Review article
C2 - 37482431
AN - SCOPUS:85165706403
SN - 0385-8146
VL - 51
SP - 174
EP - 188
JO - Auris Nasus Larynx
JF - Auris Nasus Larynx
IS - 1
ER -